Sanxin Medical: Revenue of 1.64 billion yuan in 2025, with a year-on-year net profit increase of 15.43%.

Sanxin Medical announced that the total operating income for the year 2025 was 1.64 billion yuan, an increase of 9.31% year-on-year; the net profit attributable to the shareholders of the listed company was 262 million yuan, an increase of 15.43% year-on-year; the non-recurring net profit was 239 million yuan, an increase of 14.01% year-on-year. As of the end of the reporting period, the total assets were 2.427 billion yuan, an increase of 9.19% from the beginning of the period; the owner's equity attributable to the shareholders of the listed company was 1.456 billion yuan, an increase of 9.95% from the beginning of the period; the net asset per share was 2.79 yuan/share, an increase of 10.28% from the beginning of the period. This performance report is unaudited, and specific data will be disclosed in the annual report.